MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....stability test storage conditions. Additional studies should be performed to characterize.....of each facility involved in the manufacturing of the drug substance and excipients should..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
stability guidance -draft
...this guidance to mean a batch of drug substance or drug product manufactured at the scale.....and the test methods used to monitor the stability of the drug substance and preliminary.....and the test methods used to monitor the stability of the drug product packaged in the..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=117)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....process test and the drug substance test, the acceptance criterion for the in-process test.....batches that will be tested before inclusion of the test in the drug substance..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=76)
...These regulations require documentation of the drug substance, drug product, placebo, labeling.....dissolution for solid oral dosage forms, sterility for parenterals, animal safety test for.....one in which the components or ingredients and composition of the drug substance and drug..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=73)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....process test and the drug substance test, the acceptance criterion for the in-process test.....batches that will be tested before inclusion of the test in the drug substance..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=73)
Substance
...individual batches of the drug substance used in animal and clinical testing, Drug Substance.....intermediate(s) or steps in the process to test, and the kind of testing required, are the.....Production of a drug substance, whether by synthesis, fermentation, or isolation, usually..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=70)
...Systemic exposure patterns reflect both release of the drug substance from the drug product and.....The drug content of the test product cannot differ from that of the reference listed product by more than 5.....BA data can also provide information indirectly about the properties of a drug substance before..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=50)
GUIDE TO INSPECTIONS OF ORAL SOLID DOSAGE FORMS PRE/POST APPROVAL ISSUES...
...Therefore, the finished dosage form manufacturer must perform the appropriate test to characterize the drug substance.....Therefore, review the specifications, analytical methods, and test results for the lots of the drug substance used to.....Typically the control of test batches includes, among others, drug substance characterization, granulation analyses, and dose..
http://www.fda.gov/ora/inspect_ref/igs/solid.html (score=50)
Validation of Chromatographic Methods
...both drug substance and drug product.Detection limit is the lowest concentration of analyte in.....The objective of a test method is to generate reliable and accurate data regardless of.....Solution stability of the drug substance or drug product after preparation..according to the..
http://www.fda.gov/cder/guidance/cmc3.pdf (score=47)
WAIS Document Retrieval
...For the impurity test, the discrimination may be established by spiking drug substance or drug.....In addition, the identification test may be applied to materials structurally similar to.....For example, where a titration is adopted to assay the drug substance for release, the..
http://www.fda.gov/cder/guidance/ichq2b.htm (score=44)
J:!GUIDANCFINALICHQ2B.PDF
...assay the drug substance for release, the combination of the assay and a suitable test for.....the drug product or to compare the results obtained from a second, well-characterized.....test data may have to be subjected to a mathematical transformation prior to the..
http://www.fda.gov/cder/guidance/1320fnl.pdf (score=41)
Q1B Photostability Testing of New Drug Substances and Products
...This testing may involve the drug substance alone and/or in simple solutions/suspensions to.....Care should be taken to ensure that the physical characteristics of the samples under test.....Normally, only one batch of drug substance is tested during the development phase, and then the..
http://www.fda.gov/cder/guidance/1318.htm (score=38)
GUIDE 1 Note: This document is reference materials for investigators...
...Documents relating to the formulation of the product, synthesis of the bulk drug substance.....They may accept stability test results showing an apparent increase in the assay of the.....For drug substance labs evaluate methods validation and raw data for sterility, endotoxin..
http://www.fda.gov/ora/inspect_ref/igs/pharm.html (score=27)
...Well, this is another study with the same active drug substance, drug B, and there are two.....Is the test product delivering out of the actuator the same amount of drug as the.....We're talking about the exact same drug substance in the exact same form for the exact same use..
http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3764t1.txt (score=27)
...Well, this is another study with the same active drug substance, drug B, and there are two.....Is the test product delivering out of the actuator the same amount of drug as the.....We're talking about the exact same drug substance in the exact same form for the exact same use..
http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3764t1.htm (score=27)
FR Notice ICH Guidance on Q6A Specifications: Test Procedures and Acceptance...
...The specification for solid oral dosage forms normally includes a test to measure release of drug substance from the drug.....This test is important in cases where the new drug substance is known to be hygroscopic or degraded by moisture or when the drug.....10 Impact of Drug Substance on Drug Product Specifications In general, it should not be necessary to test..
http://www.fda.gov/cber/gdlns/frich122900.htm (score=24)
iCHQ2A.
...Quantitative tests of the active moiety in samples of drug substance or..drug product or other.....are required for a quantitative test than for a limit test. Assay procedures are intended to measure the analyte.....for drug products or particle size determination for drug substance, these have..not been..
http://www.fda.gov/cder/guidance/ichq2a.pdf (score=21)
HUMAN DRUG CGMP NOTES December, 1996
...The profile of drug substance purity at release, developed over the course of process.....Concern about the potential health effects to people working with DOP test aerosols has.....Is it acceptable for a firm to use drug components, drug product containers, or drug product closures simultaneously with testing and..
http://www.fda.gov/cder/hdn/cnotesd6.htm (score=15)
Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products
...The delivery system, or the system in conjunction with the drug substance, may cause these.....A randomized, controlled, repeat patch test study that compares the test patch to the.....Application of a test patch should be discontinued at a site if predefined serious..
http://www.fda.gov/cder/guidance/2887fnl.htm (score=15)
A Drug Review Glossary
...An application that a drug sponsor must submit to FDA before beginning tests of a new drug.....that contains a drug substance--generally, but not necessarily, in association with other.....Studies that test a drug on animals and other nonhuman test systems. They must comply with..
http://www.fda.gov/fdac/special/newdrug/bengloss.html (score=13)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
